Stage IIIB Bladder Cancer AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB13007 | Enfortumab vedotin | 1 | Recruiting | 1 |
| DB12147 | Erdafitinib | 1 | Recruiting | 1 |
| DB11595 | Atezolizumab | 1 / 2 | Recruiting | 1 |
| DB11945 | Avelumab | 1 / 2 | Recruiting | 1 |
| DB11714 | Durvalumab | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB05992 | Plinabulin | 1 / 2 | Recruiting | 1 |
| DB11945 | Avelumab | 2 | Completed | 1 |
| DB14547 | Chloride ion | 2 | Completed | 1 |
| DB00515 | Cisplatin | 2 | Completed | 1 |
| DB00544 | Fluorouracil | 2 | Completed | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB00305 | Mitomycin | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Completed | 1 |
| DB12257 | Platinum | 2 | Completed | 1 |
| DB14851 | Relatlimab | 2 | Recruiting | 1 |
| DB06273 | Tocilizumab | 2 | Active Not Recruiting | 1 |